EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Regulated cell death modalities: breaking resistance of temozolomide glioblastoma therapy

Tatiana A Mishchenko, Oluwabukolami J Olajide, Ekaterina N Gorshkova, Maria V Vedunova, Dmitri V Krysko

Trends in Cancer · 2025-05 · 11 (5) · 430-432

DOI: 10.1016/j.trecan.2025.01.007 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Cancer, 2025-05. Verfasst von Tatiana A Mishchenko und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biology and Biomedicine, National Research Lobachevsky State University of Nizhny Novgorod, Nizhny Novgorod, Russia. Hauptthemen laut MEDLINE: Temozolomide, Glioblastoma, Drug Resistance, Neoplasm, Brain Neoplasms. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Temozolomide (TMZ), the standard first-line chemotherapy for glioblastoma multiforme (GBM), has been a cornerstone of treatment despite its known limitations. We propose critically assessing TMZ's potential to induce multiple regulated cell death modalities and leveraging their immunogenic properties to develop novel strategies for overcoming the resistance of GBM and enhancing its therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TemozolomideGlioblastomaDrug Resistance, NeoplasmBrain NeoplasmsAntineoplastic Agents, AlkylatingHumansCell DeathAnimalsAntineoplastic Combined Chemotherapy Protocols

Stichwörter der Autor:innen

ICDapoptosischemotherapyferroptosisglioblastomagliomaimmunogenic cell deathmixed types of cell deathnecroptosispyroptosisresistance mechanisms

Substanzen

TemozolomideAntineoplastic Agents, Alkylating

Autor:innen und Institutionen

  • Institute of Biology and Biomedicine, National Research Lobachevsky State University of Nizhny Novgorod, Nizhny Novgorod, Russia.
  • Cell Death Investigation and Therapy Laboratory, Anatomy and Embryology Unit, Department of Human Structure and Repair, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium; Cancer Research Institut…

Förderung

  • Russian Science Foundation

Zitieren

APA

Mishchenko, T. A., Olajide, O. J., Gorshkova, E. N., Vedunova, M. V., & Krysko, D. V. (2025). Regulated cell death modalities: breaking resistance of temozolomide glioblastoma therapy. Trends in Cancer, 11(5), 430-432. https://doi.org/10.1016/j.trecan.2025.01.007

Vancouver

Mishchenko TA, Olajide OJ, Gorshkova EN, Vedunova MV, Krysko DV. Regulated cell death modalities: breaking resistance of temozolomide glioblastoma therapy. Trends in Cancer. 2025;11(5):430-432. doi:10.1016/j.trecan.2025.01.007

BibTeX
@article{Mishchenko2025,
  author = {Mishchenko, Tatiana A and Olajide, Oluwabukolami J and Gorshkova, Ekaterina N and Vedunova, Maria V and Krysko, Dmitri V},
  title = {Regulated cell death modalities: breaking resistance of temozolomide glioblastoma therapy},
  journal = {Trends in Cancer},
  year = {2025},
  volume = {11},
  number = {5},
  pages = {430--432},
  doi = {10.1016/j.trecan.2025.01.007}
}
Kostenlos starten →